Collectively, our results indicated that RASSF1 acts to restrict EMT and invasion by indirectly controlling YAP nuclear shuttling and activation through a RhoB - regulated cytoskeletal remodeling process, with potential implications to delay the progression of RASSF1 -
hypermethylated lung tumors.